Plus   Neg

Vertex Pharmaceuticals Inc. Q1 adjusted earnings Beat Estimates

Vertex Pharmaceuticals Inc. (VRTX) announced a profit for its first quarter that climbed from last year.

The company's bottom line came in at $603 million, or $2.29 per share. This compares with $269 million, or $1.03 per share, in last year's first quarter.

Excluding items, Vertex Pharmaceuticals Inc. reported adjusted earnings of $674 million or $2.56 per share for the period.

Analysts had expected the company to earn $1.84 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 76.7% to $1.52 billion from $0.86 billion last year.

Vertex Pharmaceuticals Inc. earnings at a glance:

-Earnings (Q1): $674 Mln. vs. $296 Mln. last year.
-EPS (Q1): $2.56 vs. $1.14 last year.
-Analysts Estimate: $1.84
-Revenue (Q1): $1.52 Bln vs. $0.86 Bln last year.

Full year revenue guidance: $5.3 to 5.6 Bln

For comments and feedback contact: editorial@rttnews.com

Follow RTT